DOI QR코드

DOI QR Code

In vivo verification of regional hyperthermia in the liver

  • Noh, Jae Myoung (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Hye Young (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Hee Chul (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, So Hyang (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Young-Sun (Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Hong, Saet-Byul (Laboratory Animal Research Center, Samsung Biomedical Research Institute) ;
  • Park, Ji Hyun (Laboratory Animal Research Center, Samsung Biomedical Research Institute) ;
  • Jung, Sang Hoon (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Han, Youngyih (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2014.06.25
  • Accepted : 2014.09.11
  • Published : 2014.12.31

Abstract

Purpose: We performed invasive thermometry to verify the elevation of local temperature in the liver during hyperthermia. Materials and Methods: Three 40-kg pigs were used for the experiments. Under general anesthesia with ultrasonography guidance, two glass fiber-optic sensors were placed in the liver, and one was placed in the peritoneal cavity in front of the liver. Another sensor was placed on the skin surface to assess superficial cooling. Six sessions of hyperthermia were delivered using the Celsius TCS electro-hyperthermia system. The energy delivered was increased from 240 kJ to 507 kJ during the 60-minute sessions. The inter-session cooling periods were at least 30 minutes. The temperature was recorded every 5 minutes by the four sensors during hyperthermia, and the increased temperatures recorded during the consecutive sessions were analyzed. Results: As the animals were anesthetized, the baseline temperature at the start of each session decreased by $1.3^{\circ}C$ to $2.8^{\circ}C$ (median, $2.1^{\circ}C$). The mean increases in temperature measured by the intrahepatic sensors were $2.42^{\circ}C$ (95% confidence interval [CI], 1.70-3.13) and $2.67^{\circ}C$ (95% CI, 2.05-3.28) during the fifth and sixth sessions, respectively. The corresponding values for the intraperitoneal sensor were $2.10^{\circ}C$ (95% CI, 0.71-3.49) and $2.87^{\circ}C$ (1.13-4.43), respectively. Conversely, the skin temperature was not increased but rather decreased according to application of the cooling system. Conclusion: We observed mean $2.67^{\circ}C$ and $2.87^{\circ}C$ increases in temperature at the liver and peritoneal cavity, respectively, during hyperthermia. In vivo real-time thermometry is useful for directly measuring internal temperature during hyperthermia.

Keywords

References

  1. Kampinga HH, Dikomey E. Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol 2001;77:399-408. https://doi.org/10.1080/09553000010024687
  2. van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002;13:1173-84. https://doi.org/10.1093/annonc/mdf280
  3. Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 2007;19:418-26. https://doi.org/10.1016/j.clon.2007.03.015
  4. Franckena M, Lutgens LC, Koper PC, et al. Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients. Int J Radiat Oncol Biol Phys 2009;73:242-50. https://doi.org/10.1016/j.ijrobp.2008.03.072
  5. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355:1119-25. https://doi.org/10.1016/S0140-6736(00)02059-6
  6. Tilly W, Gellermann J, Graf R, Hildebrandt B, et al. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005;181:35-41. https://doi.org/10.1007/s00066-005-1296-8
  7. Milani V, Pazos M, Issels RD, et al. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther Onkol 2008;184:163-8. https://doi.org/10.1007/s00066-008-1731-8
  8. Bae SH, Park HC, Lim DH, et al. Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2012;82:e603-7. https://doi.org/10.1016/j.ijrobp.2011.09.053
  9. Lim DH, Lee H, Park HC, et al. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities. Am J Clin Oncol 2013;36:162-6. https://doi.org/10.1097/COC.0b013e3182438dae
  10. Oh D, Lim DH, Park HC, et al. Early three-dimensional con for- mal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity. Am J Clin Oncol 2010;33:370-5. https://doi.org/10.1097/COC.0b013e3181b0c298
  11. Jiang W, Zeng ZC. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma? Oncology 2013;84 Suppl 1:69-74. https://doi.org/10.1159/000345893
  12. Cha J, Seong J. Application of radiotherapeutic strategies in the BCLC-defined stages of hepatocellular carcinoma. Liver Cancer 2012;1:216-25. https://doi.org/10.1159/000343836
  13. Seong J, Lee HS, Han KH, Chon CY, Suh CO, Kim GE. Combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma. Yonsei Med J 1994;35:252-9. https://doi.org/10.3349/ymj.1994.35.3.252
  14. Hehr T, Budach W, Lamprecht U, et al. Experimental thermoradiotherapy in malignant hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2003;55:1374-80. https://doi.org/10.1016/S0360-3016(02)04615-1
  15. Lagendijk JJ, Van Rhoon GC, Hornsleth SN, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998;14:125-33. https://doi.org/10.3109/02656739809018219
  16. Bruggmoser G, Bauchowitz S, Canters R, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 2011;187:605-10. https://doi.org/10.1007/s00066-011-1145-x
  17. Wust P, Cho CH, Hildebrandt B, Gellermann J. Thermal monitoring: invasive, minimal-invasive and non-invasive approaches. Int J Hyperthermia 2006;22:255-62. https://doi.org/10.1080/02656730600661149
  18. Fatehi D, van der Zee J, Notenboom A, van Rhoon GC. Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors. Strahlenther Onkol 2007;183:479-86. https://doi.org/10.1007/s00066-007-1768-0
  19. van der Zee J, Peer-Valstar JN, Rietveld PJ, de Graaf- Strukowska L, van Rhoon GC. Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys 1998;40:1205-12. https://doi.org/10.1016/S0360-3016(98)00008-X
  20. Wust P, Gellermann J, Harder C, et al. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys 1998;41:1129-37. https://doi.org/10.1016/S0360-3016(98)00165-5
  21. Ludemann L, Wlodarczyk W, Nadobny J, Weihrauch M, Gellermann J, Wust P. Non-invasive magnetic resonance thermography during regional hyperthermia. Int J Hyperthermia 2010;26:273-82. https://doi.org/10.3109/02656731003596242
  22. Gellermann J, Hildebrandt B, Issels R, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer 2006;107:1373-82. https://doi.org/10.1002/cncr.22114
  23. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998;9(1 Pt 1):101-11. https://doi.org/10.1016/S1051-0443(98)70491-9
  24. Nagata Y, Hiraoka M, Nishimura Y, et al. Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys 1997;38:359-65. https://doi.org/10.1016/S0360-3016(96)00625-6
  25. Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. Dose- response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002;54:150-5.
  26. Roujol S, Ries M, Quesson B, Moonen C, Denis de Senneville B. Real-time MR-thermometry and dosimetry for interventional guidance on abdominal organs. Magn Reson Med 2010;63: 1080-7. https://doi.org/10.1002/mrm.22309
  27. Suh CO, Loh JJ, Sung JS, et al. Effects of Radiofrequency Induced local Hyperthermia on Normal Canine Liver. J Korean Soc Ther Radiol 1991;9:37-46.

Cited by

  1. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase vol.32, pp.3, 2016, https://doi.org/10.3109/02656736.2016.1144895
  2. Non-Invasive Radiofrequency Field Treatment to Produce Hepatic Hyperthermia: Efficacy and Safety in Swine vol.5, pp.None, 2014, https://doi.org/10.1109/jtehm.2017.2672965
  3. The Role of Radiofrequency Hyperthermia in The Radiosensitization of A Human Prostate Cancer Cell Line vol.19, pp.1, 2014, https://doi.org/10.22074/cellj.2017.4460